Overview

A Food Effect Study of 60mg ER Torsemide

Status:
Completed
Trial end date:
2018-03-31
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of a high-fat meal (food effect) on the bioavailability and pharmacokinetics of 60mg ER Torsemide tablet after single dose oral administration in healthy volunteers. The study will be conducted as a two-sequence to period crossover study to compare 60mg ER Torsemide ER bioavailability under fed and fasting conditions. 60mg ER torsemide is a new strength and dosage form.
Phase:
Phase 1
Details
Lead Sponsor:
Sarfez Pharmaceuticals, Inc.
Treatments:
Torsemide